ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Akebia Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Akebia Therapeutics, INC. (Akebia Therapeutics 401(k) Plan · EIN 20-8756903 · PN 001): $42.76M net assets, 181 active participants, and $50.13 per $10,000 (50.13 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAkebia Therapeutics, INC.
Filing IdentifierAkebia Therapeutics 401(k) Plan · EIN 20-8756903 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$42.76M
Active Participants181
Direct Admin Fee Rate$50.13 per $10,000 (50.13 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderEmpower Retirement
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI